Literature DB >> 31943821

Effect of Structural Descriptors on the Design of Cyclin Dependent Kinase Inhibitors Using Similarity-based Molecular Evolution.

Kentaro Kawai1, Yukiko Karuo1, Atsushi Tarui1, Kazuyuki Sato1, Masaaki Omote1.   

Abstract

In this study, we evaluated the effect of structural descriptors on the in silico design of bioactive compounds. The authors have proposed a molecular design technique for designing new bioactive compounds. In this approach, known fragments are combined to generate new structures, which are evolved to increase the similarity to a known active compound. We generated the structure of CDK2 inhibitors using four descriptors (three binary fingerprints and a numerical vector) to evaluate the effect of descriptors on the molecular design. Subsequently, the physicochemical properties of the generated compounds were compared and evaluated from a similarity viewpoint. As a result, it was clarified that better structures can be generated by using descriptors consisting of numerical vectors rather than binary fingerprints. Moreover, the compound generated using the numerical vector or a long-bit fingerprint resulted in favorable docking scores. Although binary fingerprints such as MACCS are widely used in this field, this result shows that it is important to use numeric vectors, or at least to use long-bit fingerprints, to design drug-like CDK2 inhibitors by the similarity-based structure generation.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cyclin dependent kinase; de novo design; descriptor; fingerprint

Mesh:

Substances:

Year:  2020        PMID: 31943821     DOI: 10.1002/minf.201900126

Source DB:  PubMed          Journal:  Mol Inform        ISSN: 1868-1743            Impact factor:   3.353


  1 in total

Review 1.  Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches.

Authors:  Hyunho Kim; Eunyoung Kim; Ingoo Lee; Bongsung Bae; Minsu Park; Hojung Nam
Journal:  Biotechnol Bioprocess Eng       Date:  2021-01-07       Impact factor: 3.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.